Loss Ratio (Annual)

Loss Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The loss ratio is calculated by taking the incurred underwriting losses and then dividing them by earned premium. Calculated as: Underwriting Losses Total / Net Premiums Earned

Ocular Therapeutix, Inc. (OCUL) Loss Ratio data is not available.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$63.72M
Net Income	$-193.51M
Cost of Goods Sold	$5.63M
Gross Profit	$58.10M
Operating Expenses	$235.50M
Operating Income	$-171.78M
Non-Operating Income/Expense	$-21.73M
Pre-Tax Income	$-193.51M
Normalized Pre-Tax Income	$-193.51M
Income after Taxes	$-193.51M
Income from Continuous Operations	$-193.51M
Consolidated Net Income/Loss	$-193.51M
Normalized Income after Taxes	$-193.51M
EBIT	$-171.78M
EBITDA	$-168.00M
Weighted-Average Shares Outstanding (Basic)	158.26M
Weighted-Average Shares Outstanding (Diluted)	158.26M
Earnings per Share (EPS) (Basic)	$-1.22
Earnings per Share (EPS) (Diluted)	$-1.22
Balance Sheet Financials
Current Assets	$440.99M
Property, Plant, and Equipment	$9.39M
Long-Term Assets	$16.95M
Total Assets	$457.94M
Current Liabilities	$41.35M
Long-Term Debt	$68.50M
Long-Term Liabilities	$101.24M
Total Liabilities	$142.59M
Common Equity	$315.34M
Tangible Shareholders Equity	$315.34M
Shareholders Equity	$315.34M
Common Shares Outstanding	157.75M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-134.68M
Cash Flow from Investing Activities	$-1.29M
Cash Flow from Financial Activities	$332.11M
Beginning Cash	$197.57M
End Cash	$393.72M
Increase/Decrease in Cash	$196.15M
Stock-Based Compensation	$33.11M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	10.66
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.18
Debt to Equity Ratio	0.22
Gross Margin	91.17%
Operating Margin	-269.57%
EBIT Margin	-269.57%
EBITDA Margin	-263.63%
Pre-Tax Profit Margin	-303.67%
Profit Margin	-303.67%
Free Cash Flow	$-135.97M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.14
Inventory Turnover	1.85
Receiveable Turnover	1.97
Days Sales in Receivables	185.52
Return on Equity	-61.36%
Return on Tangible Equity	-61.36%
Return on Assets	-42.26%
Return on Investments	-50.41%
Book Value Per Share	$2.00
Free Cash Flow per Share	$-0.86
Operating Cash Flow per Share	$-0.85

Data from Zacks Investment Research, Inc.